High heart rate: a cardiovascular risk factor?

De battre mon coeur s'est arrete—Movie by Jacques Audiard. Resting heart rate (RHR) is one of the simplest cardiovascular parameters, which usually averages 60 to 80 beats per minute (b.p.m.), but can occasionally exceed 100 b.p.m. in unconditioned, sedentary individuals and be as low as 30 b.p.m. in highly trained endurance athletes. Epidemiological evidences demonstrate that RHR, or its corollaries, namely post-exercise heart rate recovery, which is mediated primarily by vagal tone, and heart rate variability (HRV, beat-to-beat variability also mediated by autonomic nervous system, especially parasympathetic) correlates with cardiovascular morbidity and suggests that RHR determines life expectancy. Multiple studies have identified RHR as an independent risk factor for cardiovascular disease (comparable with smoking, dyslipidemia or hypertension). However, it is often overlooked. Since 1980, it is known that resting heart rate (RHR) is a prognostic factor in coronary diseased patients.1,2 Data from the Coronary Artery Surgery Study (CASS) published last year underline the prognostic importance of RHR for morbidity (time to rehospitalization), as well as total and cardiovascular mortality.3 Heart rate proves to be the best predictor after myocardial infarction,4,5 in patients with congestive heart failure, as well as in patients with diabetes mellitus or hypertension. In addition, it was found that elevated RHR is also strongly associated with mortality in the general population. For instance, in the Framingham Study, in a cohort composed of 5070 subjects who were free from cardiovascular disease at the time of entry into the study, cardiovascular and coronary mortality increased progressively with RHR6 ( Figure 1 ). In a subset of 4530 untreated hypertensive (>140 mmHg systolic or >90 mmHg diastolic) patients included in this study, using 36-year follow-up data, odds ratio (OR) for each increment in heart rate of 40 b.p.m. were 1.68–1.70 (CI: 1.08–2.67) for cardiovascular mortality and fascinatingly also 2.14–2.18 … *Corresponding author. Tel: +41 31 632 96 53; fax: +41 31 632 47 71. E-mail address : otto.hess{at}insel.ch

[1]  H. Levine Rest heart rate and life expectancy. , 1997, Journal of the American College of Cardiology.

[2]  Coburn Af,et al.  Observations on the relation of heart rate, life span, weight and mineralization in the digoxin-treated A-J mouse. , 1971 .

[3]  J. Kjekshus,et al.  Haemodynamic and metabolic effects of timolol (Blocadren) on ischaemic myocardium. , 2009, Acta Medica Scandinavica.

[4]  S. Cook Coronary artery disease, nitric oxide and oxidative stress: the "Yin-Yang" effect--a Chinese concept for a worldwide pandemic. , 2006, Swiss medical weekly.

[5]  X. Xu,et al.  Role of EDRF/NO in parasympathetic coronary vasodilation following carotid chemoreflex activation in conscious dogs. , 1994, The American journal of physiology.

[6]  D. DiFrancesco Cardiac pacemaker /f current and its inhibition by heart rate-reducing agents , 2005, Current medical research and opinion.

[7]  C. Lewis,et al.  Evidence for a gene influencing heart rate on chromosome 4 among hypertensives , 2002, Human Genetics.

[8]  B. Pannier,et al.  Role of modifiable risk factors in life expectancy in the elderly , 2005, Journal of hypertension.

[9]  L. Hittinger,et al.  Contributions of heart rate and contractility to myocardial oxygen balance during exercise. , 2003, American journal of physiology. Heart and circulatory physiology.

[10]  S. Giampaoli,et al.  Heart rate as a predictor of mortality: the MATISS project. , 2001, American journal of public health.

[11]  E Casiglia,et al.  Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. , 1997, Hypertension.

[12]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[13]  CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[14]  C. Bulpitt,et al.  Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. , 2002, Archives of internal medicine.

[15]  G. Wilkinson,et al.  Life history, ecology and longevity in bats , 2002, Aging cell.

[16]  E Casiglia,et al.  High heart rate: a risk factor for cardiovascular death in elderly men. , 1999, Archives of internal medicine.

[17]  C. Nicol,et al.  PPARgamma in endothelial cells influences high fat diet-induced hypertension. , 2005, American journal of hypertension.

[18]  J. Giles Could astronauts sleep their way to the stars , 2004 .

[19]  J. Kjekshus,et al.  Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. , 1986, The American journal of cardiology.

[20]  U. Heidland,et al.  Left Ventricular Muscle Mass and Elevated Heart Rate Are Associated With Coronary Plaque Disruption , 2001, Circulation.

[21]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[22]  S. Manuck,et al.  Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. , 1987, Circulation.

[23]  G S Wagner,et al.  Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. , 1998, JAMA.

[24]  L. Fried,et al.  Relation of heart rate at rest and mortality in the Women's Health and Aging Study. , 2003, The American journal of cardiology.

[25]  J. Stessman,et al.  Sex Differences in the Effect of Heart Rate on Mortality in the Elderly , 2003, Journal of the American Geriatrics Society.

[26]  G. Dobson,et al.  ON BEING THE RIGHT SIZE: HEART DESIGN, MITOCHONDRIAL EFFICIENCY and LIFESPAN POTENTIAL , 2003, Clinical and experimental pharmacology & physiology.

[27]  J. Loscalzo,et al.  Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. , 1996, The American journal of physiology.

[28]  L. Guize,et al.  Combined effects of heart rate and pulse pressure on cardiovascular mortality according to age , 2001, Journal of hypertension.

[29]  R. Ferrari Editorial: heart rate , 2003 .

[30]  R Dietz,et al.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.

[31]  A. Mallet,et al.  Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001, Circulation.

[32]  PhilippeLechat,et al.  Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001 .

[33]  C. Nicol,et al.  PPARγ in endothelial cells influences high fat diet-induced hypertension , 2005 .

[34]  Lisa J. Martin,et al.  Major Quantitative Trait Locus for Resting Heart Rate Maps to a Region on Chromosome 4 , 2004, Hypertension.

[35]  Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. , 1996, Journal of the American College of Cardiology.

[36]  P Ducimetière,et al.  Predicting sudden death in the population: the Paris Prospective Study I. , 1999, Circulation.

[37]  C. Zarins,et al.  Retarding effect of lowered heart rate on coronary atherosclerosis. , 1984, Science.

[38]  M. Zaugg,et al.  Cellular mechanisms in sympatho-modulation of the heart. , 2004, British journal of anaesthesia.

[39]  J. Montani,et al.  Loss of nocturnal dipping of blood pressure and heart rate in obesity-induced hypertension in rabbits , 2001, Autonomic Neuroscience.

[40]  C. DeWitt,et al.  Pharmacology, Pathophysiology and Management of Calcium Channel Blocker and β-Blocker Toxicity , 2004, Toxicological reviews.

[41]  R. Olshen,et al.  A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. , 2002, American journal of human genetics.

[42]  H A Lindberg,et al.  Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. , 1980, American journal of epidemiology.

[43]  J. Feldman,et al.  Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. , 1991, American heart journal.

[44]  D. Paterson,et al.  Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice. , 2001, American journal of physiology. Heart and circulatory physiology.

[45]  P Ducimetière,et al.  Prognostic significance of exercise blood pressure and heart rate in middle-aged men. , 1992, Hypertension.

[46]  藤浦 芳久 Heart rate and mortality in a Japanese general population : an 18-year follow-up study , 2001 .

[47]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[48]  Giuseppe Mancia,et al.  Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. , 2006, Journal of hypertension.

[49]  D Kromhout,et al.  Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). , 2001, Journal of clinical epidemiology.

[50]  Azbel MYa,et al.  Universal biological scaling and mortality , 1994 .

[51]  J. Thaden,et al.  Loss of diurnal rhythms of blood pressure and heart rate caused by high-fat feeding. , 2005, American journal of hypertension.

[52]  W. Aronow,et al.  Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. , 1996, The American journal of cardiology.

[53]  E Kristal-Boneh,et al.  The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study) , 2000, European heart journal.

[54]  D. DiFrancesco,et al.  Properties of ivabradine‐induced block of HCN1 and HCN4 pacemaker channels , 2006, The Journal of physiology.

[55]  P. Vollenweider,et al.  Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. , 2003, Swiss medical weekly.

[56]  J. Loscalzo,et al.  Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. , 1995, The Journal of clinical investigation.

[57]  Å. Hjalmarson Significance of reduction in heart rate in cardiovascular disease. , 1998, Clinical cardiology.

[58]  J. Ross,et al.  Mechanism of Beneficial Effect of β‐Adrenergic Blockade on Exercise‐Induced Myocardial Ischemia in Conscious Dogs , 1987, Circulation research.

[59]  Joseph L. Izzo,et al.  Pet Ownership, but Not ACE Inhibitor Therapy, Blunts Home Blood Pressure Responses to Mental Stress , 2001, Hypertension.

[60]  L. Guize,et al.  Cardiovascular Mortality in Hypertensive Men According to Presence of Associated Risk Factors , 2001, Hypertension.

[61]  R B D'Agostino,et al.  Influence of heart rate on mortality among persons with hypertension: the Framingham Study. , 1993, American heart journal.

[62]  P. Vollenweider,et al.  Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension. , 2004, Diabetes.

[63]  P. Macfarlane,et al.  Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. , 1993, British heart journal.

[64]  S Glagov,et al.  Experimental atherosclerosis at the carotid bifurcation of the cynomolgus monkey. Localization, compensatory enlargement, and the sparing effect of lowered heart rate. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[65]  D. Gutterman,et al.  Inhibition of nitric oxide synthesis augments centrally induced sympathetic coronary vasoconstriction in cats. , 1994, The American journal of physiology.

[66]  L Guize,et al.  Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. , 1999, Hypertension.

[67]  Jean-Claude Tardif,et al.  Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. , 2005, European heart journal.

[68]  J Ross,et al.  Influence of heart rate on mortality after acute myocardial infarction. , 1990, The American journal of cardiology.

[69]  D. Levy,et al.  Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study. , 1996, Archives of internal medicine.

[70]  U. Goldbourt,et al.  The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. , 1995, Journal of clinical epidemiology.

[71]  S. Snyder,et al.  Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. , 1998, The Journal of clinical investigation.

[72]  L. Hittinger,et al.  Effect of Graded Heart Rate Reduction with Ivabradine on Myocardial Oxygen Consumption and Diastolic Time in Exercising Dogs , 2004, Journal of Pharmacology and Experimental Therapeutics.

[73]  C. Sartori,et al.  Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans. , 2005, Pharmacology & therapeutics.

[74]  D. Kass,et al.  Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart. , 1998, The Journal of clinical investigation.

[75]  D. Levy,et al.  Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study. , 1989, American journal of epidemiology.

[76]  H. Ross,et al.  Nitric oxide and cardiac autonomic control in humans. , 2000, Hypertension.

[77]  L. Tavazzi Heart rate as a therapeutic target in heart failure , 2003 .

[78]  R S Paffenbarger,et al.  Heart rate and cardiovascular mortality: the Framingham Study. , 1987, American heart journal.

[79]  B. Singh,et al.  Increased heart rate as a risk factor for cardiovascular disease , 2003 .

[80]  A. Coburn,et al.  Observations on the relation of heart rate, life span, weight and mineralization in the digoxin-treated A-J mouse. , 1971, The Johns Hopkins medical journal.